Levin Law

The spotlight on pharmaceutical giant Novo Nordisk shifted this week from Ozempic/Wegovy gastroparesis lawsuits to a grilling on the drugs’ prices. On Tuesday, the company’s CEO, Lars Fruergaard Jørgensen, faced intense scrutiny during a U.S. Senate hearing over the high cost of the company’s popular diabetes and weight-loss drugs. While senators criticized the corporation for […]

Gastroparesis, also known as stomach paralysis, is not typically life-threatening, but complications from the condition can be fatal. Stomach paralysis can create multiple, serious health complications, such as: What is Gastroparesis? According to Mayo Clinic, Gastroparesis is a condition that affects the normal movement of the muscles in your stomach. Usually, strong muscle contractions push […]

On May 8, 2024, the U.S. District Judge Gene E.K. Pratter entered Case Management Order No. 6 establishing the expanded Leadership Structure in the “Ozempic lawsuits” [IN RE: GLUGAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION (MDL 3094)]. Levin Papantonio Rafferty (LPR) Attorney Cameron Stephenson was appointed to the Plaintiffs’ Executive Committee in this […]